Home > Insider Trading > Filing (0001567619-21-002490)

Filing Details

Accession Number:: 0001567619-21-002490
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-02-08 18:05:31
Reporting Period:: 2021-02-04

Accepted Time:: 2021-02-08 18:05:31
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
874716	Idexx Laboratories Inc	IDXX	In Vitro & In Vivo Diagnostic Substances (2835)	010393723

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1094176	Anne M Szostak	One Idexx Drive Westbrook ME 04092		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-02-04	5,974	$64.69	5,974	No	4	M	Direct
Common Stock	Acquisiton	2021-02-04	5,902	$85.00	11,876	No	4	M	Direct
Common Stock	Disposition	2021-02-04	11,876	$0.00	0	No	4	G	Direct
Common Stock	Acquisiton	2021-02-04	11,876	$0.00	11,876	No	4	G	Indirect	Trust of M. Anne Szostak
Common Stock	Disposition	2021-02-04	2,791	$488.24	9,085	No	4	S	Indirect	Trust of M. Anne Szostak
Common Stock	Disposition	2021-02-04	4,286	$489.23	4,799	No	4	S	Indirect	Trust of M. Anne Szostak
Common Stock	Disposition	2021-02-04	3,399	$490.70	1,400	No	4	S	Indirect	Trust of M. Anne Szostak
Common Stock	Disposition	2021-02-04	1,100	$491.56	300	No	4	S	Indirect	Trust of M. Anne Szostak
Common Stock	Disposition	2021-02-04	300	$492.39	0	No	4	S	Indirect	Trust of M. Anne Szostak
Common Stock	Disposition	2021-02-05	10,217	$0.00	0	No	5	G	Indirect	2020 Szostak IDEXX GRAT
Common Stock	Acquisiton	2021-02-05	10,217	$0.00	10,217	No	5	G	Indirect	Trust of M. Anne Szostak
Common Stock	Disposition	2021-02-04	10,217	$0.00	0	No	5	G	Indirect	Trust of M. Anne Szostak
Common Stock	Acquisiton	2021-02-05	10,217	$0.00	10,217	No	5	G	Indirect	2021 Szostak IDEXX GRAT

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	M	Direct
No	4	G	Direct
No	4	G	Indirect	Trust of M. Anne Szostak
No	4	S	Indirect	Trust of M. Anne Szostak
No	4	S	Indirect	Trust of M. Anne Szostak
No	4	S	Indirect	Trust of M. Anne Szostak
No	4	S	Indirect	Trust of M. Anne Szostak
No	4	S	Indirect	Trust of M. Anne Szostak
No	5	G	Indirect	2020 Szostak IDEXX GRAT
No	5	G	Indirect	Trust of M. Anne Szostak
No	5	G	Indirect	Trust of M. Anne Szostak
No	5	G	Indirect	2021 Szostak IDEXX GRAT

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right-to-buy)	Disposition	2021-02-04	5,974	$0.00	5,974	$64.69
Common Stock	Non-Qualified Stock Option (right-to-buy)	Disposition	2021-02-04	5,902	$0.00	5,902	$85.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2024-05-06	No	4	M	Direct
0		2026-05-03	No	4	M	Direct

Footnotes

The reporting person is the settlor of the Trust of M. Anne Szostak ("Trust") and the trustee of the Trust, has power to direct the distribution of Trust assets, and has the power to revoke or amend the Trust. The reporting person has a pecuniary interest in the shares transferred to the Trust.
Represents the weighted average price of the shares sold ranging from a low of $488.00 to a high of $489.00 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $489.01 to a high of $490.01 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $490.02 to a high of $491.00 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $491.05 to a high of $492.00 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $492.31 to a high of $492.46 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
The reporting person is the settlor and trustee of the 2021 Szostak IDEXX GRAT (the "GRAT"). The GRAT is irrevocable, and the reporting person disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein.
Grant of option to buy 2,987 shares of IDEXX Laboratories, Inc. common stock that became exercisable in one installment on May 7, 2015 without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the "Stock Split"). The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split.
Grant of option to buy 5,902 shares of IDEXX Laboratories, Inc. common stock that became exercisable in one installment on May 4, 2016.
Not applicable.